-
Something wrong with this record ?
Increased expression of mutant forms of p53 oncogene in primary lung cancer
R. Iggo, K. Gatter, J. Bartek, D. Lane, AL. Harris,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
1969059
Knihovny.cz E-resources
- MeSH
- Adenocarcinoma analysis genetics MeSH
- Alleles MeSH
- Autoradiography MeSH
- DNA, Neoplasm analysis MeSH
- Phosphoproteins analysis genetics MeSH
- Immunohistochemistry MeSH
- Carcinoid Tumor analysis genetics MeSH
- Humans MeSH
- Chromosomes, Human, Pair 17 * MeSH
- Carcinoma, Small Cell analysis genetics MeSH
- RNA, Messenger analysis MeSH
- Molecular Sequence Data MeSH
- Mutation * MeSH
- Tumor Suppressor Protein p53 MeSH
- Lung Neoplasms analysis genetics MeSH
- Oligonucleotide Probes MeSH
- Oncogene Proteins analysis genetics MeSH
- Polymerase Chain Reaction MeSH
- Amino Acid Sequence MeSH
- Carcinoma, Squamous Cell analysis genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Primary lung cancer samples of the major histological types were examined for expression of the tumor suppressor gene p53 by immunohistochemistry. Abnormalities in p53 expression were found in 28 of 40 carcinomas, 14 of 17 squamous tumours showing abnormal p53 expression, whereas no expression of p53 was detectable in 7 carcinoid tumours or in 10 normal lung samples. Direct evidence for homozygous expression of mutant p53 mRNA in representative carcinomas was obtained by means of an asymmetric polymerase chain reaction mRNA sequencing strategy, which allowed sequencing without any cloning step. All the mutations were G to T transversions resulting in mis-sense mutations in aminoacids highly conserved in evolution. Mutation of the p53 gene is the most frequently identified genetic change in human lung cancer; these findings suggest that simple immunohistological methods can provide strong evidence of such mutation.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15000872
- 003
- CZ-PrNML
- 005
- 20151013124939.0
- 007
- ta
- 008
- 150112s1990 enk f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)1969059
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Iggo, R
- 245 10
- $a Increased expression of mutant forms of p53 oncogene in primary lung cancer / $c R. Iggo, K. Gatter, J. Bartek, D. Lane, AL. Harris,
- 520 9_
- $a Primary lung cancer samples of the major histological types were examined for expression of the tumor suppressor gene p53 by immunohistochemistry. Abnormalities in p53 expression were found in 28 of 40 carcinomas, 14 of 17 squamous tumours showing abnormal p53 expression, whereas no expression of p53 was detectable in 7 carcinoid tumours or in 10 normal lung samples. Direct evidence for homozygous expression of mutant p53 mRNA in representative carcinomas was obtained by means of an asymmetric polymerase chain reaction mRNA sequencing strategy, which allowed sequencing without any cloning step. All the mutations were G to T transversions resulting in mis-sense mutations in aminoacids highly conserved in evolution. Mutation of the p53 gene is the most frequently identified genetic change in human lung cancer; these findings suggest that simple immunohistological methods can provide strong evidence of such mutation.
- 650 _2
- $a adenokarcinom $x analýza $x genetika $7 D000230
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a autoradiografie $7 D001345
- 650 _2
- $a karcinoid $x analýza $x genetika $7 D002276
- 650 _2
- $a malobuněčný karcinom $x analýza $x genetika $7 D018288
- 650 _2
- $a spinocelulární karcinom $x analýza $x genetika $7 D002294
- 650 12
- $a lidské chromozomy, pár 17 $7 D002886
- 650 _2
- $a DNA nádorová $x analýza $7 D004273
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a nádory plic $x analýza $x genetika $7 D008175
- 650 _2
- $a molekulární sekvence - údaje $7 D008969
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a oligonukleotidové sondy $7 D015345
- 650 _2
- $a onkogenní proteiny $x analýza $x genetika $7 D015513
- 650 _2
- $a fosfoproteiny $x analýza $x genetika $7 D010750
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a messenger RNA $x analýza $7 D012333
- 650 _2
- $a nádorový supresorový protein p53 $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Gatter, K
- 700 1_
- $a Bártek, Jiří, $d 1953- $7 xx0046271
- 700 1_
- $a Lane, D
- 700 1_
- $a Harris, A L
- 773 0_
- $w MED00010161 $t Lancet $x 0140-6736 $g Roč. 335, č. 8691 (1990), s. 675-679
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/1969059 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150112 $b ABA008
- 991 __
- $a 20151013125128 $b ABA008
- 999 __
- $a ok $b bmc $g 1057896 $s 883590
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 1990 $b 335 $c 8691 $d 675-679 $i 0140-6736 $m Lancet $n Lancet $x MED00010161
- LZP __
- $a Pubmed-20150112